State Street
LEGN icon

State Street’s Legend Biotech LEGN Stock Holding History

State Street’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$43.3M Buy
1,498,704
+332
+0% +$8.96K ﹤0.01% 1941
2026
Q1 		$27.1M Sell
1,498,372
-17,996
-1% -$343K ﹤0.01% 2075
2025
Q4 		$33M Buy
1,516,368
+359,246
+31% +$10.3M ﹤0.01% 1984
2025
Q3 		$37.7M Buy
1,157,122
+37,431
+3% +$1.38M ﹤0.01% 1878
2025
Q2 		$39.7M Sell
1,119,691
-18,498
-2% -$599K ﹤0.01% 1801
2025
Q1 		$38.6M Buy
1,138,189
+17,896
+2% +$642K ﹤0.01% 1777
2024
Q4 		$36.5M Sell
1,120,293
-19,929
-2% -$826K ﹤0.01% 1875
2024
Q3 		$55.6M Buy
1,140,222
+4,735
+0.4% +$252K ﹤0.01% 1650
2024
Q2 		$50.3M Buy
1,135,487
+87,485
+8% +$4.04M ﹤0.01% 1676
2024
Q1 		$58.8M Buy
1,048,002
+11,257
+1% +$679K ﹤0.01% 1639
2023
Q4 		$62.4M Buy
1,036,745
+171,159
+20% +$10.8M ﹤0.01% 1584
2023
Q3 		$58.1M Sell
865,586
-28,969
-3% -$2.01M ﹤0.01% 1533
2023
Q2 		$61.8M Sell
894,555
-44,895
-5% -$2.93M ﹤0.01% 1529
2023
Q1 		$45.3M Buy
939,450
+139,077
+17% +$6.8M ﹤0.01% 1715
2022
Q4 		$40M Buy
800,373
+34,548
+5% +$1.67M ﹤0.01% 1786
2022
Q3 		$31.2M Buy
765,825
+58,042
+8% +$2.72M ﹤0.01% 1920
2022
Q2 		$38.9M Buy
707,783
+25,437
+4% +$1.07M ﹤0.01% 1815
2022
Q1 		$24.8M Buy
682,346
+27,178
+4% +$1.07M ﹤0.01% 2245
2021
Q4 		$30.5M Buy
655,168
+543,026
+484% +$27.5M ﹤0.01% 2164
2021
Q3 		$5.67M Buy
112,142
+4,179
+4% +$174K ﹤0.01% 3171
2021
Q2 		$4.43M Buy
107,963
+17,152
+19% +$583K ﹤0.01% 3307
2021
Q1 		$2.63M Buy
90,811
+8,630
+11% +$235K ﹤0.01% 3321
2020
Q4 		$2.31M Buy
+82,181
New +$2.37M ﹤0.01% 3305

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

State Street's LEGN Position: Q2 2026 in Review

State Street increased its Legend Biotech (LEGN) stake by 0.02% in Q2 2026, buying an estimated $8.96K and bringing the position to 1,498,704 shares worth $43.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1941.

State Street first reported a position in LEGN in Q4 2020 and has held it in 23 quarters since. The position peaked at $62.4M in Q4 2023. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • State Street held 1,498,704 shares of Legend Biotech worth $43.3M as of Q2 2026.
  • State Street bought 332 Legend Biotech shares in Q2 2026, an estimated $8.96K.
  • Legend Biotech made up ﹤0.01% of State Street's portfolio in Q2 2026, its #1941 holding.
  • State Street first reported a position in Legend Biotech in Q4 2020 and has held it in 23 quarters since.
  • State Street's Legend Biotech position peaked at $62.4M in Q4 2023.
  • 219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.